Drug
chlorproguanil-dapsone
chlorproguanil-dapsone is a pharmaceutical drug with 6 clinical trials. Historical success rate of 66.7%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 4 completed trials
Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(33%)
Phase Distribution
Ph not_applicable
1
17%
Ph phase_1
1
17%
Ph phase_2
1
17%
Ph phase_3
3
50%
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
3(50.0%)
N/ANon-phased studies
1(16.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
4 of 6 finished
Non-Completion Rate
33.3%
2 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(4)
Terminated(2)
Detailed Status
Completed4
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 33 (50.0%)
N/A1 (16.7%)
Trials by Status
terminated233%
completed467%
Recent Activity
0 active trials
Showing 5 of 6
terminatedphase_1
Chlorproguanil-Dapsone in Pregnant Women
NCT00126971
terminatedphase_3
IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.
NCT00361114
completedphase_2
Kilimanjaro IPTi Drug Options Trial
NCT00158574
completedphase_3
A Trial of Antimalarial Drugs Used in Pregnancy in Tanzania
NCT00146731
completedphase_3
Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria
NCT00371735
Clinical Trials (6)
Showing 6 of 6 trials
NCT00126971Phase 1
Chlorproguanil-Dapsone in Pregnant Women
NCT00361114Phase 3
IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.
NCT00158574Phase 2
Kilimanjaro IPTi Drug Options Trial
NCT00146731Phase 3
A Trial of Antimalarial Drugs Used in Pregnancy in Tanzania
NCT00371735Phase 3
Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria
NCT00111163Not Applicable
Intermittent Preventive Treatment With Antimalarials in Kenyan Infants
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6